Subscribe To
Iovance biotherapeutics to present at jefferies global healthcare conference
SAN CARLOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing
June 9, 2023, 11:01 am
Iovance biotherapeutics to present at jefferies global healthcare conference
SAN CARLOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing
June 9, 2023, 7:01 am
Ultragenyx to participate in the goldman sachs 44th annual global healthcare conference
NOVATO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developme...
June 7, 2023, 9:00 pm
Atara biotherapeutics to participate in the goldman sachs 44th annual global healthcare conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its <...
June 7, 2023, 4:01 pm
Aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023
SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company f...
June 7, 2023, 11:30 am
Artelo biosciences selected for oral presentation to report positive research findings on art12.11 at the 33rd annual international cannabinoid research society symposium
ART12.11, a novel and Patented Cocrystal of Cannabidiol, Improves Bioavailability and Efficacy of CBD ...
June 7, 2023, 8:30 am
Aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023
SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company fo...
June 7, 2023, 7:30 am
Arbutus to present ab-729 and ab-836 data at easl congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveragin...
June 7, 2023, 6:01 am
Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in science advances demonstrating potent in vitro and in vivo antimicrobial activity
novel antibiotics were developed by Spexis in close collaboration with Professor Oliver Zerbe’s group...
June 7, 2023, 5:15 am
Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in science advances demonstrating potent in vitro and in vivo antimicrobial activity
novel antibiotics were developed by Spexis in close collaboration with Professor Oliver Zerbe’s group...
June 7, 2023, 5:15 am
Arbutus to present ab-729 and ab-836 data at easl congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...
June 7, 2023, 2:01 am
Reata pharmaceuticals announces participation in the goldman sachs 44th annual global healthcare conference
PLANO, Texas--(BUSINESS WIRE)--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a global...
June 6, 2023, 4:31 pm
Bruker's (brkr) latest workflows to aid applied markets
Bruker (BRKR) introduces novel EVOQ DART-TQ+ for chromatography-free mass spectrometry for applied mark...
June 6, 2023, 9:14 am
Ocular therapeutix™ to present 12-month top-line data from u.s.-based phase 1 clinical trial of otx-tki in wet age-related macular degeneration at the 2023 clinical trials at the summit annual meeting
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...
June 5, 2023, 4:01 pm
Ocugen, inc. announces business advisory board
MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...
June 5, 2023, 11:02 am
Elicio therapeutics reports inducement grant to new chief financial officer
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics (Nasdaq: ELTX), a clinical-stage biotechnology company developing a pipeline of ...
June 2, 2023, 8:30 pm
Tracon pharmaceuticals to present at the jefferies healthcare conference
SAN DIEGO, June 02, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the d...
June 2, 2023, 12:00 pm
Inozyme pharma to present at the jefferies healthcare conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing
June 2, 2023, 11:30 am
Aclaris therapeutics to participate in two june healthcare investor conferences
WAYNE, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develo...
June 2, 2023, 11:00 am
Bayer (bayry) & cedilla to co-develop novel cancer therapies
Bayer (BAYRY) announces licensing agreement with Cedilla Therapeutics to jointly develop and commercialize the latter's selective protein complex inhi...
June 2, 2023, 8:23 am